Graham Capital Management L.P. Sells 24,983 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Graham Capital Management L.P. lowered its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 16.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 127,324 shares of the pharmacy operator's stock after selling 24,983 shares during the quarter. Graham Capital Management L.P.'s holdings in Walgreens Boots Alliance were worth $1,188,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Vanguard Group Inc. grew its stake in shares of Walgreens Boots Alliance by 2.7% in the fourth quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator's stock valued at $805,506,000 after acquiring an additional 2,279,495 shares in the last quarter. Invesco Ltd. raised its holdings in Walgreens Boots Alliance by 8.8% in the 4th quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator's stock valued at $303,902,000 after buying an additional 2,631,332 shares during the last quarter. Geode Capital Management LLC raised its holdings in Walgreens Boots Alliance by 5.2% in the 4th quarter. Geode Capital Management LLC now owns 20,779,254 shares of the pharmacy operator's stock valued at $194,082,000 after buying an additional 1,020,587 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in Walgreens Boots Alliance by 19.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator's stock valued at $122,737,000 after purchasing an additional 2,185,950 shares during the period. Finally, Northern Trust Corp increased its position in Walgreens Boots Alliance by 18.8% during the 4th quarter. Northern Trust Corp now owns 8,896,742 shares of the pharmacy operator's stock valued at $83,007,000 after purchasing an additional 1,407,973 shares during the period. Institutional investors own 58.59% of the company's stock.

Insider Buying and Selling at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Chairman Stefano Pessina acquired 832,258 shares of Walgreens Boots Alliance stock in a transaction that occurred on Sunday, April 27th. The stock was acquired at an average price of $11.01 per share, with a total value of $9,163,160.58. Following the purchase, the chairman now owns 145,621,079 shares in the company, valued at approximately $1,603,288,079.79. This trade represents a 0.57% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 17.50% of the stock is owned by company insiders.

Walgreens Boots Alliance Price Performance

Shares of WBA traded up $0.11 during mid-day trading on Friday, reaching $11.29. 5,903,657 shares of the company's stock were exchanged, compared to its average volume of 21,007,260. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The company has a 50-day simple moving average of $11.02 and a two-hundred day simple moving average of $10.34. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $18.45. The company has a market cap of $9.76 billion, a price-to-earnings ratio of -1.10, a PEG ratio of 1.31 and a beta of 0.77.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.10. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $38.59 billion during the quarter, compared to analysts' expectations of $37.90 billion. During the same period in the previous year, the company earned $1.20 EPS. The business's quarterly revenue was up 4.1% compared to the same quarter last year. On average, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

WBA has been the topic of a number of recent research reports. Wolfe Research upgraded Walgreens Boots Alliance to a "hold" rating in a report on Monday, February 24th. StockNews.com assumed coverage on Walgreens Boots Alliance in a research note on Tuesday. They issued a "hold" rating for the company. Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a "hold" rating to a "sell" rating and decreased their price objective for the company from $11.00 to $9.00 in a report on Friday, February 28th. Finally, Truist Financial decreased their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a report on Friday, January 31st. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, Walgreens Boots Alliance currently has an average rating of "Hold" and a consensus price target of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.